Aortic Balloon Catheter Recall: May Rupture During Surgery

A Class I recall has been issued for Edwards Lifesciences CardioVations EndoClamp Aortic Catheters, which are used during heart bypass surgery. The FDA and device manufacturer indicate that the balloon catheters may rupture during surgery, potentially causing a fatal injury for the patient.

The aortic balloon catheter recall was announced by the FDA and Edwards Lifesciences on Monday for devices manufactured between August 2008 and August 2009, which were distributed between November 2008 and September 2009.

The FDA classified the action as a Class I recall, which represents the most serious type of medical device recall. Although no information was provided by the FDA about any reports of injuries or deaths associated with the defective balloon catheters, Class I recalls are issued in situations where there is a reasonable probability that use of the recalled product will cause serious injury or death.

Sports-Betting-Addiction-Lawsuits
Sports-Betting-Addiction-Lawsuits

The recall applies to Edwards Lifesciences CardioVations EndoClamp Aortic Catheters model numbers EC 1001 and EC65. The balloon catheters are used during heart bypass surgery to block off the aorta. They also monitor aortic pressure and stop the heart during cardiopulmonary bypass operations.

Edwards Lifesciences sent a letter to their customers on October 29 instructing them to check their inventory and identify any of the unused recalled aortic balloon catheters impacted by this recall. Unused products should be returned to the company and any adverse events linked to problems with the catheters should be reported to the FDA’s MedWatch Adverse Event Reporting program.


0 Comments


Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

MORE TOP STORIES

A federal judge wants lawyers involved in hair relaxer lawsuits to provide an update this week on the status of discovery proceedings for a pool of cases being considered for bellwether trial dates.
Two Covidien Parietex Optimized Composite hernia mesh lawsuits have been chosen to be prepared to potentially serve as the third Covidien hernia mesh bellwether trial.
Six women have filed a joint, multiplaintiff BioZorb tissue marker lawsuit, all indicating that they suffered injuries and complications due to the recalled device’s defective design.